Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Clinical trial NCT01215357 · COMPLETED
Trial details
- NCT number
- NCT01215357
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-05-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.